Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) CEO Margaret Tooth sold 491 shares of the stock in a transaction on Monday, May 25th. The shares were sold at an average price of $21.86, for a total value of $10,733.26. Following the transaction, the chief executive officer directly owned 176,379 shares of the company’s stock, valued at approximately $3,855,644.94. The trade was a 0.28% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Trupanion Stock Performance
Shares of NASDAQ TRUP opened at $21.69 on Thursday. The stock has a fifty day moving average price of $25.08 and a two-hundred day moving average price of $30.52. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.73 and a current ratio of 1.73. The firm has a market cap of $946.12 million, a P/E ratio of 36.76 and a beta of 1.49. Trupanion, Inc. has a 1 year low of $21.16 and a 1 year high of $57.88.
Trupanion (NASDAQ:TRUP – Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The financial services provider reported $0.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.07 by $0.04. The firm had revenue of $384.05 million during the quarter, compared to analyst estimates of $379.77 million. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The firm’s quarterly revenue was up 12.3% on a year-over-year basis. During the same period last year, the company posted ($0.03) EPS. Research analysts forecast that Trupanion, Inc. will post 0.53 EPS for the current fiscal year.
Institutional Trading of Trupanion
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on the company. Bank of America cut their price objective on Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a research report on Tuesday, April 14th. Zacks Research downgraded Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 13th. Cantor Fitzgerald cut their price objective on Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a research report on Thursday, April 9th. Weiss Ratings lowered Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, March 4th. Finally, Stifel Nicolaus reduced their target price on Trupanion from $35.00 to $31.00 and set a “hold” rating for the company in a report on Tuesday, March 31st. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $42.25.
Read Our Latest Stock Analysis on TRUP
About Trupanion
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Read More
- Five stocks we like better than Trupanion
- Dick’s Sporting Goods Isn’t Done Winning Yet
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
